The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS)
Open accessAbstract
BACKGROUND: Anemia is an established negative prognostic factor in myelodysplastic syndromes but the relationship between its degree and clinical outcome is poorly defined. We, therefore, studied the relationship between severity of anemia and outcome in myelodysplastic syndrome patients. DESIGN AND METHODS: We studied 840 consecutive patients diagnosed with myelodysplastic syndromes at the Fondazione IRCCS Policlinico San Matteo, Pavia, Italy, and 504 patients seen at the Heinrich-Heine-University Hospital, Düsseldorf, Germany. Hemoglobin levels were monitored longitudinally and analyzed by means of time-dependent Cox's proportional hazards regression models. RESULTS: Hemoglobin levels lower than 9 g/dL in males (HR 5.56, P=0.018) and 8 g/dL in females (HR=5.35, P=0.026) were independently related to reduced overall survival, higher risk of non-leukemic death and cardiac death (P<0.001). Severe anemia, defined as hemoglobin below these thresholds, was found to be as effective as transfusion-dependency in the prognostic assessment. After integrating this definition of severe anemia into the WHO classification-based Prognostic Scoring System, time-dependent regression and landmark analyses showed that the refined model was able to identify risk groups with different survivals at any time during follow up. CONCLUSIONS: Accounting for severity of anemia through the WHO classification-based Prognostic Scoring System provides an objective criterion for prognostic assessment and implementation of risk-adapted treatment strategies in myelodysplastic syndrome patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new look at the statistical model identification
Akaike, H. (1974) · IEEE Transactions on Automatic Control · doi:10.1109/tac.1974.1100705 · Cited by 51,879
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
Swerdlow, S. H. (2017) · Medical Entomology and Zoology · Cited by 12,933
International scoring system for evaluating prognosis in myelodysplastic syndromes
Greenberg, P., Cox, C., LeBeau, M. M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., et al. (1997) · Blood · doi:10.1182/blood.v89.6.2079 · Cited by 4,427
ANew Look at the Statistical Model Identification
AKAlKE, H. (2011) · Cited by 4,177
WHO classification of haematolymphoid tumours
Gaillard, F., Weerakkody, Y., & Sharma, R. (2010) · Radiopaedia.org · doi:10.53347/rid-9250 · Cited by 3,776
Proposals for the classification of the myelodysplastic syndromes
Bennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A. G., Gralnick, H. R., & Sultan, C. (1982) · British Journal of Haematology · doi:10.1111/j.1365-2141.1982.tb08475.x · Cited by 3,627
Sorror, M. L., Maris, M. B., Storb, R., Baron, F., Sandmaier, B. M., Maloney, D. G., & Storer, B. (2005) · Blood · doi:10.1182/blood-2005-05-2004 · Cited by 2,969
The World Health Organization (WHO) classification of the myeloid neoplasms
Vardiman, J. W., Harris, N. L., & Brunning, R. D. (2002) · Blood · doi:10.1182/blood-2002-04-1199 · Cited by 2,197
Proposals for the classification of the myelodysplastic syndromes
Bennett, J. M., Catovsky, D., Daniel, M., Flandrin, G., Galton, D. A. G., Gralnick, H. R., & Sultan, C. (1982) · British Journal of Haematology · doi:10.1111/j.1365-2141.1982.tb02771.x · Cited by 1,275
IEEE TRANSACTIONS ON AUTOMATIC CONTROL
Antsaklis, P. J., Kovács, E., Chong, E., Grizzle, J. W., Krstić, M., Spall, J. C., Amamoto, Y. Y., Arzelier, D., Astolfi, A., Braslavsky, J. H., et al. (2006) · Cited by 1,251
Malcovati, L., Germing, U., Kuendgen, A., Della Porta, M. G., Pascutto, C., Invernizzi, R., Giagounidis, A., Hildebrandt, B., Bernasconi, P., Knipp, S., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.5696 · Cited by 1,032
Self-citationMalcovati, L., Porta, M. G. D., Pascutto, C., Invernizzi, R., Boni, M., Travaglino, E., Passamonti, F., Arcaini, L., Maffioli, M., Bernasconi, P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.7038 · Cited by 865
Self-citationHaase, D., Germing, U., Schanz, J., Pfeilstöcker, M., Nösslinger, T., Hildebrandt, B., Kundgen, A., Lübbert, M., Kunzmann, R., Giagounidis, A. A. N., et al. (2007) · Blood · doi:10.1182/blood-2007-03-082404 · Cited by 794
Self-citationAnemia and Mortality in Heart Failure Patients
Groenveld, H. F., Januzzi, J. L., Damman, K., van Wijngaarden, J., Hillege, H. L., van Veldhuisen, D. J., & van der Meer, P. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.04.061 · Cited by 764
Kantarjian, H., O'Brien, S., Ravandi, F., Cortes, J., Shan, J., Bennett, J. M., List, A., Fenaux, P., Sanz, G., Issa, J., et al. (2008) · Cancer · doi:10.1002/cncr.23697 · Cited by 482
Myelodysplastic Syndromes — Coping with Ineffective Hematopoiesis
Cazzola, M., & Malcovati, L. (2005) · New England Journal of Medicine · doi:10.1056/nejmp048266 · Cited by 343
Self-citationPark, S., Grabar, S., Kelaidi, C., Beyne-Rauzy, O., Picard, F., Bardet, V., Coiteux, V., Leroux, G., Lepelley, P., Daniel, M.-T., et al. (2008) · Blood · doi:10.1182/blood-2007-06-096370 · Cited by 334
Sorror, M. L., Giralt, S., Sandmaier, B. M., De Lima, M., Shahjahan, M., Maloney, D. G., Deeg, H. J., Appelbaum, F. R., Storer, B., & Storb, R. (2007) · Blood · doi:10.1182/blood-2007-06-096966 · Cited by 326
Sorror, M. L., Maris, M. B., Storb, R. F., Baron, F., Sandmaier, B. M., Maloney, D. G., & Barry, S. E. (2005) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2004.12.067 · Cited by 323
Jädersten, M., Malcovati, L., Dybedal, I., Giovanni Della Porta, M., Invernizzi, R., Montgomery, S. M., Pascutto, C., Porwit, A., Cazzola, M., & Hellström-Lindberg, E. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.4906 · Cited by 300
Self-citationGoldberg, S. L., Chen, E., Corral, M., Guo, A., Mody-Patel, N., Pecora, A. L., & Laouri, M. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.2395 · Cited by 289
Opasich, C., Cazzola, M., Scelsi, L., De Feo, S., Bosimini, E., Lagioia, R., Febo, O., Ferrari, R., Fucili, A., Moratti, R., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi388 · Cited by 287
Self-citationAul, C., Gattermann, N., Heyll, A., Germing, U., Derigs, G., & Schneider, W. (1992) · PubMed · Cited by 265
Self-citationDella Porta, M. G., Malcovati, L., Boveri, E., Travaglino, E., Pietra, D., Pascutto, C., Passamonti, F., Invernizzi, R., Castello, A., Magrini, U., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.2246 · Cited by 254
Self-citationDella Porta, M. G., Malcovati, L., Strupp, C., Ambaglio, I., Kuendgen, A., Zipperer, E., Travaglino, E., Invernizzi, R., Pascutto, C., Lazzarino, M., et al. (2011) · Haematologica · doi:10.3324/haematol.2010.033506 · Cited by 243
Self-citationAnalysis of Survival by Tumor Response and Other Comparisons of Time-to-Event by Outcome Variables
Anderson, J. R., Cain, K. C., & Gelber, R. D. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.1000 · Cited by 228
Alessandrino, E. P., Della Porta, M. G., Bacigalupo, A., Van Lint, M. T., Falda, M., Onida, F., Bernardi, M., Iori, A. P., Rambaldi, A., Cerretti, R., et al. (2008) · Blood · doi:10.1182/blood-2008-03-143735 · Cited by 195
Self-citationCause of death in patients with lower‐risk myelodysplastic syndrome
Dayyani, F., Conley, A. P., Strom, S. S., Stevenson, W., Cortes, J. E., Borthakur, G., Faderl, S., O'Brien, S., Pierce, S., Kantarjian, H., et al. (2010) · Cancer · doi:10.1002/cncr.24984 · Cited by 180
Myelodysplastic Syndromes/Neoplasms—Overview
Naeim, F., Nagesh Rao, P., Song, S. X., & Grody, W. W. (2013) · Atlas of Hematopathology · doi:10.1016/b978-0-12-385183-3.00008-5 · Cited by 166
Alessandrino, E. P., Porta, M. G. D., Bacigalupo, A., Malcovati, L., Angelucci, E., Van Lint, M. T., Falda, M., Onida, F., Bernardi, M., Guidi, S., et al. (2010) · Haematologica · doi:10.3324/haematol.2009.011429 · Cited by 165
Self-citationTang, W. H. W., Tong, W., Jain, A., Francis, G. S., Harris, C. M., & Young, J. B. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.07.094 · Cited by 164
Riva, E., Tettamanti, M., Mosconi, P., Apolone, G., Gandini, F., Nobili, A., Tallone, M. V., Detoma, P., Giacomin, A., Clerico, M., et al. (2008) · Haematologica · doi:10.3324/haematol.13449 · Cited by 144
Sperr, W. R., Wimazal, F., Kundi, M., Baumgärtner, C., Nösslinger, T., Makrai, A., Stauder, R., Krieger, O., Pfeilstöcker, M., & Valent, P. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp258 · Cited by 116
Kao, J. M., McMillan, A., & Greenberg, P. L. (2008) · American Journal of Hematology · doi:10.1002/ajh.21249 · Cited by 103
Natural history of idiopathic refractory sideroblastic anemia
Cazzola, M., Barosi, G., Gobbi, P. G., Invernizzi, R., Riccardi, A., & Ascari, E. (1988) · Blood · doi:10.1182/blood.v71.2.305.305 · Cited by 98
Self-citationWang, R., Gross, C. P., Halene, S., & Ma, X. (2009) · Leukemia Research · doi:10.1016/j.leukres.2009.02.005 · Cited by 90
How I treat patients with myelodysplastic syndromes
Stone, R. M. (2009) · Blood · doi:10.1182/blood-2008-09-038935 · Cited by 90
Prognostic Classification and Risk Assessment in Myelodysplastic Syndromes
Cazzola, M., & Malcovati, L. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.02.005 · Cited by 46
Self-citationEvaluation of comorbidities at diagnosis predicts outcome in myelodysplastic syndrome patients
Breccia, M., Federico, V., Latagliata, R., Mercanti, C., D’Elia, G. M., Cannella, L., Loglisci, G., Salaroli, A., Santopietro, M., & Alimena, G. (2010) · Leukemia Research · doi:10.1016/j.leukres.2010.06.005 · Cited by 39
Risk assessment in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
Cazzola, M. (2011) · Haematologica · doi:10.3324/haematol.2010.030023 · Cited by 23
Self-citation
Cited by
Revised International Prognostic Scoring System for Myelodysplastic Syndromes
Greenberg, P. L., Tuechler, H., Schanz, J., Sanz, G., Garcia-Manero, G., Solé, F., Bennett, J. M., Bowen, D., Fenaux, P., Dreyfus, F., et al. (2012) · Blood · doi:10.1182/blood-2012-03-420489 · Cited by 2,844
Self-citationThe genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia
Sperling, A. S., Gibson, C. J., & Ebert, B. L. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.112 · Cited by 678
Malcovati, L., Hellström-Lindberg, E., Bowen, D., Adès, L., Cermak, J., del Cañizo, C., Della Porta, M. G., Fenaux, P., Gattermann, N., Germing, U., et al. (2013) · Blood · doi:10.1182/blood-2013-03-492884 · Cited by 669
Self-citationMalcovati, L., Papaemmanuil, E., Bowen, D. T., Boultwood, J., Della Porta, M. G., Pascutto, C., Travaglino, E., Groves, M. J., Godfrey, A. L., Ambaglio, I., et al. (2011) · Blood · doi:10.1182/blood-2011-09-377275 · Cited by 498
Self-citationElena, C., Gallì, A., Such, E., Meggendorfer, M., Germing, U., Rizzo, E., Cervera, J., Molteni, E., Fasan, A., Schuler, E., et al. (2016) · Blood · doi:10.1182/blood-2016-05-714030 · Cited by 361
Self-citation
Metadata
- Authors
- Malcovati, L., Della Porta, M. G., Strupp, C., Ambaglio, I., Kuendgen, A., Nachtkamp, K., Travaglino, E., Invernizzi, R., Pascutto, C., Lazzarino, M., Germing, U., & Cazzola, M.
- Venue
- Haematologica
- Published
- 2011-06-09
- Volume
- 96
- Issue
- 10
- Pages
- 1433-1440
- ISSN
- 0390-6078 (ISSN-L)
- 1592-8721
- OpenAlex
- W2134702041
- Cited by
- 282
- References
- 41
- FWCI
- 16.03
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.